These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 7687499
1. Gene-specific modulation of RNA synthesis and degradation by extremely low frequency electromagnetic fields. Greene JJ, Pearson SL, Skowronski WJ, Nardone RM, Mullins JM, Krause D. Cell Mol Biol (Noisy-le-grand); 1993 May; 39(3):261-8. PubMed ID: 7687499 [Abstract] [Full Text] [Related]
2. Specific region of the c-myc promoter is responsive to electric and magnetic fields. Lin H, Goodman R, Shirley-Henderson A. J Cell Biochem; 1994 Mar; 54(3):281-8. PubMed ID: 8200908 [Abstract] [Full Text] [Related]
3. Post-transcriptional and transcriptional control of collagen gene expression in normal and modulated rabbit corneal endothelial cells. Kay EP, He YG. Invest Ophthalmol Vis Sci; 1991 May; 32(6):1821-7. PubMed ID: 1709626 [Abstract] [Full Text] [Related]
4. No effect of 60 Hz electromagnetic fields on MYC or beta-actin expression in human leukemic cells. Lacy-Hulbert A, Wilkins RC, Hesketh TR, Metcalfe JC. Radiat Res; 1995 Oct; 144(1):9-17. PubMed ID: 7568776 [Abstract] [Full Text] [Related]
5. HuD, a neuronal-specific RNA-binding protein, is a putative regulator of N-myc pre-mRNA processing/stability in malignant human neuroblasts. Lazarova DL, Spengler BA, Biedler JL, Ross RA. Oncogene; 1999 Apr 29; 18(17):2703-10. PubMed ID: 10348344 [Abstract] [Full Text] [Related]
6. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer. Ou X, Campau S, Slusher R, Jasti RK, Mabry M, Kalemkerian GP. Oncogene; 1996 Nov 07; 13(9):1893-9. PubMed ID: 8934535 [Abstract] [Full Text] [Related]
7. Changes in polyamines, c-myc and c-fos gene expression in osteoblast-like cells exposed to pulsed electromagnetic fields. De Mattei M, Gagliano N, Moscheni C, Dellavia C, Calastrini C, Pellati A, Gioia M, Caruso A, Stabellini G. Bioelectromagnetics; 2005 Apr 07; 26(3):207-14. PubMed ID: 15768429 [Abstract] [Full Text] [Related]
8. Short exposures to 60 Hz magnetic fields do not alter MYC expression in HL60 or Daudi cells. Saffer JD, Thurston SJ. Radiat Res; 1995 Oct 07; 144(1):18-25. PubMed ID: 7568767 [Abstract] [Full Text] [Related]
9. Mechanism of action of the synthetic imidazole compound YM 534 on human promyelocytic leukemia line HL-60 cells. Kanamaru R, Ishioka C, Konishi Y, Ishikawa A, Shibata H, Wakui A. Anticancer Drug Des; 1989 Aug 07; 4(2):137-44. PubMed ID: 2803462 [Abstract] [Full Text] [Related]
15. Investigations of mechanisms of drug-induced changes in gene expression: N-methylformamide-induced changes in synthesis of the M(r) 72,000 constitutive heat shock protein during commitment of HL-60 cells to granulocyte differentiation. Beere HM, Morimoto RI, Hickman JA. Cancer Res; 1993 Jul 01; 53(13):3034-9. PubMed ID: 8319210 [Abstract] [Full Text] [Related]
16. [Effects of extremely low frequency electromagnetic fields on the level of c-fos mRNA in brain and liver of mouse]. Liu Y, Yu YM, Weng EQ. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Oct 01; 21(5):335-8. PubMed ID: 14761393 [Abstract] [Full Text] [Related]
17. Apoptosis induced by oxysterol in CEM cells is associated with negative regulation of c-myc. Ayala-Torres S, Zhou F, Thompson EB. Exp Cell Res; 1999 Jan 10; 246(1):193-202. PubMed ID: 9882528 [Abstract] [Full Text] [Related]
18. Transforming growth factor-beta 1 regulates the expression of Pax-2, a developmental control gene, in renal tubule cells. Liu S, Cieslinski DA, Funke AJ, Humes HD. Exp Nephrol; 1997 Jan 10; 5(4):295-300. PubMed ID: 9259183 [Abstract] [Full Text] [Related]
19. C-myc expression is down-regulated in mafosfamide-treated HL-60 cells undergoing apoptosis. Davidoff AN, Mendelow BV. Anticancer Res; 1993 Jan 10; 13(4):1167-70. PubMed ID: 8352540 [Abstract] [Full Text] [Related]
20. The three-substituted indolinone cyclin-dependent kinase 2 inhibitor 3-[1-(3H-imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) kills human leukemia cells via down-regulation of Mcl-1 through a transcriptional mechanism. Gao N, Kramer L, Rahmani M, Dent P, Grant S. Mol Pharmacol; 2006 Aug 10; 70(2):645-55. PubMed ID: 16672643 [Abstract] [Full Text] [Related] Page: [Next] [New Search]